Review of the test used for measuring therapeutic compliance in clinical practice;Revisión de tests de medición del cumplimiento terapéutico utilizados en la práctica clínica

Atencion Primaria

Volumn 40, Issue 8, 2008, Pages 413-417

  Rodríguez Chamorro, Miguel Ángel ^a   García Jiménez, Emilio ^b   Amariles, Pedro ^c   Rodríguez Chamorro, Alfonso ^a   José Faus, María ^d  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b Centro de Atención Farmacéutica CAF Stada   (Spain)

^c UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^d UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL THERAPY; ARTICLE; CLINICAL PRACTICE; COMORBIDITY; ECONOMIC ASPECT; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; INTERPERSONAL COMMUNICATION; PSYCHOMETRY; QUESTIONNAIRE; HUMAN; PATIENT COMPLIANCE; STANDARD;

HUMANS; PATIENT COMPLIANCE; QUESTIONNAIRES;

EID: 59449099481     PISSN: 02126567     EISSN: 15781275     Source Type: Journal    
DOI: 10.1157/13125407     Document Type: Article

References (24)

1. Rodríguez Chamorro M.A., Rodríguez Chamorro A., and García Jiménez E. Incumplimiento terapéutico en pacientes en seguimiento farmacoterapéutico mediante el método Dáder. Pharmaceutical Care España 8 (2006) 62-68
2. Blackwell B. Drug therapy compliance. N Engl J Med 289 (1973) 249-252
3. Roca-Cusachs A. Estrategias de intervención para mejorar el cumplimiento. Med Clin (Barc) 116 Suppl 2 (2001) 56-62
4. García Jiménez E. Incumplimiento como causa de problema relacionado con medicamentos en el seguimiento farmacoterapéutico [Tesis Doctoral]. Granada; 2003.
5. WHO. Adherence to long-therm therapies. Evidence for action. Geneve: World Health Organization; 2004.
6. Palop Larrea V., and Martínez Mir I. Adherencia al tratamiento en el paciente anciano. Información Terapéutic del Sistema Nacional de Salud 28 (2004) 113-120
7. Donovan J.L. Patient decision making. The missing ingredient in compliance research. Int J Technol Assess Health Care 11 (1995) 443-455
8. Morisky D.E., Green L.W., and Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24 (1986) 67-74
9. Val Jiménez A., Amorós Ballestero G., Martínez P., Fernández M.L., and León M. Estudio descriptivo del cumplimiento del tratamiento farmacológico antihipertensivo y validación del test de Morisky y Green. Aten Primaria 10 (1992) 767-770
10. Knobel H., Alonso J., Casado J.L., Collazos J., González J., Ruiz I., et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS 16 (2002) 605-613
11. Thompson K., Kulkarni J., and Segejew A.A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 42 (2000) 241-247
12. Krapek K., King K., Warren S.S., George K.G., Caputo D.A., Mihelich K., et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother 38 (2004) 1357-1361
13. Chang M.C., Chang Y.C., Chiou J.F., Tsou T.S., and Lin C.C. Overcoming patient-related barriers to cancer pain management for home care patients: a pilot study. Cancer Nurs 25 (2002) 470-476
14. Turbi C., Herrero-Beaumont G., Acebes J.C., Torrijos A., Grana J., Miguélez R., et al. Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective nonrandomized, observational study. Clin Ther 26 (2004) 245-256
15. Davis N.J., Billet H.H., Cohen H.W., and Arnsten J.H. Impact of adherence, knowledge, and quality of life on anticoagulation control. Ann Pharmacother 39 (2005) 632-636
16. Jabary N.S., Castrodeza J., Monfa J.M., Sousa F., Plagaro M.F., and Martin A. Validación de un nuevo test para determinar el cumplimiento terapéutico en pacientes hipertensos: test Hermes. Hipertensión 16 (1999) 298-303
17. Herrera Carranza J. El incumplimiento terapéutico como problema relacionado con medicamentos diferenciado. Pharm Care Esp 3 (2001) 446-448
18. Ventura-Cerdá J.M., Mínguez-Gallego C., Fernández-Villalba E.M., Alós-Almiñana M., and Andrés-Soler J. Escala simplificada para detectar problemas de adherencia (ESPA) al tratamiento retroviral. Farm Hosp 30 (2006) 171-176
19. George J., Kong D.C.M., Thoman R., and Steward K. Factors associated with medication nonadherence in patients with COPD. Chest 128 (2005) 3198-3204
20. Starsvad B.L., Chewning B.A., Sleath B.L., and Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 37 (1999) 113-124
21. Krass I., Taylor S.J., Smith C., and Armour C.L. Impact on medication use and adherence of Australian pharmacists' diabetes care services. J Am Pharm Assoc 45 (2005) 33-40
22. Gwenn W., Nelemans P., Van Wijk B., Broers N., Schouten J., and Prins M. Determinants of poor adherence in hypertensive patients: Development and validation of the «Maastrich Utrecht Adherence in Hypertension (MUAH)-questionnaire». Patient Educ Couns 64 (2006) 151-158
23. Cirici R. La adherencia al tratamiento de los pacientes psicóticos. Rev Psiq Fac Med Barna 29 (2002) 232-238
24. Weiden Rapkin B., Mott T., Zygmunt A., Goldman D., Horvitz-Lennon M., and Frances A. Rating of Medication Influences (ROMI). Scale in schizopfrenia. Schiz Bull 20 (1994) 297-310